Charlotte Hateley
Impact in
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Hepatitis B Virus Studies 3
- Adipokines, Inflammation, and Metabolic Diseases 1
- Surgery 3
- Pancreatic function and diabetes 2
- Abdominal vascular conditions and treatments 1
- Co-authors
- Jacques Behmoaras (4 shared papers)Antoni Olona (4 shared papers)Sneha Muralidharan (1 shared paper)Federico Torta (1 shared paper)Markus R. Wenk (1 shared paper)Matthew Routledge (1 shared paper)Simon M. Collin (1 shared paper)Jennifer Roe (1 shared paper)
- Journals
- British Journal of Pharmacology (2 papers)Journal of Visualized Experiments (2 papers)The Lancet (1 paper)BMC Biology (1 paper)The Lancet Global Health (1 paper)
- Partner nations
- United KingdomSingaporeUnited States
In The Last Decade
Charlotte Hateley
8 papers receiving 253 citations
Peers
Comparison fields: 5 of 61
- Pharmacology 67
- Hepatology 26
- Immunology 39
- Epidemiology 58
- Biochemistry 10
Countries citing papers authored by Charlotte Hateley
This map shows the geographic impact of Charlotte Hateley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Hateley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Hateley more than expected).
Fields of papers citing papers by Charlotte Hateley
This network shows the impact of papers produced by Charlotte Hateley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Hateley. The network helps show where Charlotte Hateley may publish in the future.
Co-authors
The 25 scholars most cited alongside Charlotte Hateley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 90 | |
| 2 | 2021 | 76 | |
| 3 | 2021 | 21 | |
| 4 | 2019 | 19 | |
| 5 | 2023 | 17 | |
| 6 | 2021 | 16 | |
| 7 | 2024 | 14 | |
| 8 | 2019 | 2 | |
| 9 | 2015 | 0 |
About Charlotte Hateley
Charlotte Hateley is a scholar working on Epidemiology, Surgery, Immunology, Hepatology and Infectious Diseases, having authored 9 papers that have together received 255 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (3 papers), Liver physiology and pathology (2 papers), Immune cells in cancer (2 papers), Pancreatic function and diabetes (2 papers), Infectious Disease Case Reports and Treatments (1 paper), Abdominal vascular conditions and treatments (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper) and Eicosanoids and Hypertension Pharmacology (1 paper). The work is most often cited by research in Pharmacology (67 citations), Hepatology (26 citations), Immunology (39 citations), Epidemiology (58 citations) and Biochemistry (10 citations). Charlotte Hateley has collaborated with scholars based in United Kingdom, Singapore and United States. Frequent co-authors include Jacques Behmoaras, Antoni Olona, Sneha Muralidharan, Federico Torta, Markus R. Wenk, Matthew Routledge, Simon M. Collin, Jennifer Roe, Harriet Davidson and Rohma Ghani. Their work appears in journals such as British Journal of Pharmacology, Journal of Visualized Experiments, The Lancet, BMC Biology and The Lancet Global Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.